AOD-9604, which is also known as Tyr-hGH Frag 176-191, is a modified version of the hGH fragment 176-191 peptide. This peptide is derived from human growth hormone (hGH) and contains a disulfide bridge.
Originally created as a lipolytic compound for treating obesity, AOD-9604 has demonstrated potential in animal studies for treating heart disease, osteoarthritis, and metabolic syndrome by promoting cartilage repair and fat breakdown while inhibiting fat creation.
Studies have indicated that AOD-9604 can stimulate lipolysis without affecting insulin or IGF1 levels, suggesting that it may not lead to the development of diabetes or glucose intolerance. Furthermore, since it shares structural similarities with HGH, it is less likely to cause immunogenic reactions, making it a promising treatment candidate that is safe to study.
AOD-9604 has demonstrated potent lipolytic activity without impacting glucose levels, tissue growth, or inducing overeating.
Unlike hGH, AOD-9604 has a distinct mechanism of action that activates fat degradation and oxidation through means independent of the hGH receptor. Through laboratory experimentation on various animals, including rodents, pigs, dogs, and humans, the unique mechanism of AOD-9604 has been identified, which primarily stimulates the release of fat from adipose tissue, inhibits the accumulation of new fat in adipocytes, and promotes fat oxidation. AOD-9604 is particularly remarkable for its ability to decrease fat stores in the abdominal region.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION.
ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.